186 related articles for article (PubMed ID: 15989783)
1. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity].
Hao DF; Ma ZH; Wang YP; Rexidan ; Zhang FC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):428-31. PubMed ID: 15989783
[TBL] [Abstract][Full Text] [Related]
2. [Prokaryotic expression of HPV 16L1 and optimization of expression conditions].
Peng FY; Jiang HR; Chen YX; Chen SZ; Lin ZH; Peng FL; Zhao WB; Chen BD
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):395-8. PubMed ID: 20731039
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
[TBL] [Abstract][Full Text] [Related]
4. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
[TBL] [Abstract][Full Text] [Related]
5. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
[TBL] [Abstract][Full Text] [Related]
6. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
Gu Y; Wei M; Wang D; Li Z; Xie M; Pan H; Wu T; Zhang J; Li S; Xia N
Vaccine; 2017 Aug; 35(35 Pt B):4637-4645. PubMed ID: 28736197
[TBL] [Abstract][Full Text] [Related]
8. [Efficient expression of human papillomavirus type 16 (HPV16) capsid proteins L1 and L2 in E. coli].
Wang W; Zhou L; Sun Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):358-61. PubMed ID: 12759977
[TBL] [Abstract][Full Text] [Related]
9. The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response.
Bissa M; Zanotto C; Pacchioni S; Volonté L; Venuti A; Lembo D; De Giuli Morghen C; Radaelli A
Antiviral Res; 2015 Apr; 116():67-75. PubMed ID: 25660110
[TBL] [Abstract][Full Text] [Related]
10. A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice.
Motavalli Khiavi F; Arashkia A; Golkar M; Nasimi M; Roohvand F; Azadmanesh K
J Immunol Res; 2018; 2018():9464186. PubMed ID: 29854852
[No Abstract] [Full Text] [Related]
11. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859
[TBL] [Abstract][Full Text] [Related]
12. [Prokaryotic expression and purification of human papillomavirus type 11 L2E7 fusion protein vaccine and its immunnogenicity].
Zhang H; Zhao L; Ren J; Gao J; Bian T; Fan JT; Ruan L; Chen XQ; Tian HW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):156-8. PubMed ID: 17653322
[TBL] [Abstract][Full Text] [Related]
13. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A
Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of protein expression feature and construction of procaryotic expression system for human papillomavirus type 16 (HPV-16) E4 gene].
Wang BN; Shi QF; Li H; Zhang WD; Zhuang YH; Yang J; Jiang ZH; Li MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):361-4. PubMed ID: 16761408
[TBL] [Abstract][Full Text] [Related]
15. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity.
Schädlich L; Senger T; Kirschning CJ; Müller M; Gissmann L
Vaccine; 2009 Mar; 27(10):1511-22. PubMed ID: 19174177
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.
Pineo CB; Hitzeroth II; Rybicki EP
Plant Biotechnol J; 2013 Oct; 11(8):964-75. PubMed ID: 23924054
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins.
Windram OP; Weber B; Jaffer MA; Rybicki EP; Shepherd DN; Varsani A
Arch Virol; 2008; 153(3):585-9. PubMed ID: 18175039
[TBL] [Abstract][Full Text] [Related]
18. Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles.
Patel MC; Patkar KK; Basu A; Mohandas KM; Mukhopadhyaya R
Indian J Med Res; 2009 Sep; 130(3):213-8. PubMed ID: 19901429
[TBL] [Abstract][Full Text] [Related]
19. [Construction of prokaryotic expression vector of HPV16E6 gene and its expression].
Peng F; Jiang H; Peng F; Zhao W; Lin Z; Chen Y; Chen S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):847-50. PubMed ID: 20842857
[TBL] [Abstract][Full Text] [Related]
20. Fusion of HPV L1 into Shigella surface IcsA: a new approach in developing live attenuated Shigella-HPV vaccine.
Xu D; Wang D; Yang X; Cao M; Yu J; Wang Y
Antiviral Res; 2014 Feb; 102():61-9. PubMed ID: 24333518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
